CB
Publicaties op Oncologisch.com
A phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patiënten met HR-po...
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 8-year...
Atezolizumab plus paclitaxel versus placebo plus paclitaxel bij TNBC: IMpassion131 fase III